Revvity signals software unveils unified data platform to accelerate drug discovery

Waltham, mass.--(business wire)--today, revvity, inc. announced that its software and informatics division, revvity signals software, will launch its signals one™, a unified software platform evolved from the company's existing research portfolio, designed to streamline data management across the entire drug discovery lifecycle. the signals one platform addresses the growing complexity of drug modalities research by delivering a complete solution that integrates advanced research capabilities a.
RVTY Ratings Summary
RVTY Quant Ranking